Ftse Mib
34.825,01
-1,62%
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
71.351,87
-0,14%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lantheus Holdings Inc (LNTH) Lantheus Holdings Inc (LNTH) Notizie

Lantheus Holdings Inc

LNTH
82,87
3,20 (4,02%)
20 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/5/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202422:43EDGAR2Form 8-K - Current report
15/5/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202422:30GLOBELantheus Announces Executive Appointments to Accelerate..
13/5/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202417:19EDGAR2Form 144 - Report of proposed sale of securities
02/5/202413:00GLOBELantheus Reports First Quarter 2024 Financial Results
18/4/202414:00GLOBELantheus to Host First Quarter 2024 Earnings Conference Call..
11/3/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202416:46EDGAR2Form 144 - Report of proposed sale of securities
06/3/202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202414:30GLOBELantheus to Present at the Leerink Partners Global Biopharma..
04/3/202423:44EDGAR2Form 144 - Report of proposed sale of securities
04/3/202414:30GLOBELantheus Announces the FDA Approval of DEFINITY® (Perflutren..
28/2/202414:30GLOBELantheus Announces Promotion of Amanda Morgan to Chief..
26/2/202414:30GLOBELantheus to Present at the TD Cowen 44th Annual Health Care..
22/2/202413:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202413:47EDGAR2Form 8-K - Current report
22/2/202413:00GLOBELantheus Reports Fourth Quarter and Full Year 2023 Financial..
15/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:18EDGAR2Form 144 - Report of proposed sale of securities
13/2/202414:30GLOBELantheus Announces Collaboration to Provide Novel Tau..
08/2/202414:00GLOBELantheus to Host Fourth Quarter and Full Year 2023 Earnings..
26/1/202413:59EDGAR2Form 8-K - Current report
23/1/202414:00EDGAR2Form 8-K - Current report
23/1/202413:45GLOBELantheus Announces CEO Succession Plan
18/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202418:05EDGAR2Form 144 - Report of proposed sale of securities
11/1/202414:00GLOBELantheus Announces Acceptance of its First-to-File ANDA for..
09/1/202414:00GLOBELantheus Expands Radiopharmaceutical Oncology Pipeline via..
09/1/202413:57EDGAR2Form 8-K - Current report
09/1/202413:55GLOBELantheus Reports Preliminary Fiscal Year 2023 Revenue
03/1/202414:30GLOBELantheus to Present at the 42nd Annual J.P. Morgan..
19/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 79,96 Min: 79,50 Max: 82,88
Chiusura: 79,67

La tua Cronologia

NASDAQ
LNTH
Lantheus
USOTC
IFBC
Italian Food and Beverage (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network